Table 3. Unadjusted hazard ratios (HRs) by CDCP1 positivity and clinicopathological characteristics.

	Disease-free survival			Distant disease-free survival
	HR	95% CIa	pb	HR	95% CIa	pb
CDCP1 IHC-positive	2.52	1.01–6.32	0.045	2.57	0.94–7.04	0.065
CDCP1 FISH-positive	2.95	1.33–6.53	0.008	3.40	1.44–8.04	0.005
Age ≥ 50 yr	1.05	0.46–2.38	0.906	1.01	0.42–2.44	0.981
N-positive	4.59	1.90–11.11	0.001	4.65	1.80–12.06	0.002
Tumor size > 2.0 cm	2.81	1.27–6.22	0.011	2.41	1.02–5.72	0.045
DCIS c	2.67	1.16–6.13	0.021	2.99	1.19–7.51	0.020
Ki-67-positived	0.79	0.27–2.33	0.674	0.98	0.29–3.35	0.974

^aCI, confidence interval; DCIS, ductal carcinoma in situ.

^bEvaluated by Wald test.

^cDCIS, ductal carcinoma in situ

^dKi-67-positive, Ki-67 > 14%.